USA Remicade Biosimilar Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Biosimilar can be defined as a type of biological product that is highly similar to an already FDA approved drug, known as reference biological product. 

    This report offers an overview of the market trends, drivers, and barriers with respect to the USA Remicade Biosimilar market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Remicade Biosimilar market. Detailed analysis of key players, along with key growth strategies adopted by Remicade Biosimilar industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Celltrion

    • Novartis (Sandoz)

    • Hospira

    • Genentech (Roche Group)

    • Biocon

    • LG Life Sciences

    • Merck Serono (Merck Group)

    • Synthon Pharmaceuticals

    By Type:

    • 100mg/10ml

    • 500mg/50ml

    By End-User:

    • Blood Disorders

    • Oncology Diseases

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Remicade Biosimilar Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Remicade Biosimilar Market Size and Growth Rate of 100mg/10ml from 2016 to 2027

      • 1.3.2 USA Remicade Biosimilar Market Size and Growth Rate of 500mg/50ml from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Remicade Biosimilar Market Size and Growth Rate of Blood Disorders from 2016 to 2027

      • 1.4.2 USA Remicade Biosimilar Market Size and Growth Rate of Oncology Diseases from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Remicade Biosimilar Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Remicade Biosimilar Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Remicade Biosimilar Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Remicade Biosimilar Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Remicade Biosimilar Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Remicade Biosimilar by Major Types

      • 3.4.1 Market Size and Growth Rate of 100mg/10ml

      • 3.4.2 Market Size and Growth Rate of 500mg/50ml

    4 Segmentation of Remicade Biosimilar Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Remicade Biosimilar by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Remicade Biosimilar in Blood Disorders

      • 4.4.2 Market Size and Growth Rate of Remicade Biosimilar in Oncology Diseases

    5 Market Analysis by Regions

    • 5.1 USA Remicade Biosimilar Production Analysis by Regions

    • 5.2 USA Remicade Biosimilar Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Remicade Biosimilar Landscape Analysis

    • 6.1 West USA Remicade Biosimilar Landscape Analysis by Major Types

    • 6.2 West USA Remicade Biosimilar Landscape Analysis by Major End-Users

    7 South USA Remicade Biosimilar Landscape Analysis

    • 7.1 South USA Remicade Biosimilar Landscape Analysis by Major Types

    • 7.2 South USA Remicade Biosimilar Landscape Analysis by Major End-Users

    8 Middle West USA Remicade Biosimilar Landscape Analysis

    • 8.1 Middle West USA Remicade Biosimilar Landscape Analysis by Major Types

    • 8.2 Middle West USA Remicade Biosimilar Landscape Analysis by Major End-Users

    9 Northeast USA Remicade Biosimilar Landscape Analysis

    • 9.1 Northeast USA Remicade Biosimilar Landscape Analysis by Major Types

    • 9.2 Northeast USA Remicade Biosimilar Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Celltrion

        • 10.1.1 Celltrion Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Novartis (Sandoz)

        • 10.2.1 Novartis (Sandoz) Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Hospira

        • 10.3.1 Hospira Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Genentech (Roche Group)

        • 10.4.1 Genentech (Roche Group) Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Biocon

        • 10.5.1 Biocon Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 LG Life Sciences

        • 10.6.1 LG Life Sciences Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Merck Serono (Merck Group)

        • 10.7.1 Merck Serono (Merck Group) Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Synthon Pharmaceuticals

        • 10.8.1 Synthon Pharmaceuticals Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Remicade Biosimilar Market Size and Growth Rate of 100mg/10ml from 2016 to 2027

    • Figure USA Remicade Biosimilar Market Size and Growth Rate of 500mg/50ml from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Remicade Biosimilar Market Size and Growth Rate of Blood Disorders from 2016 to 2027

    • Figure USA Remicade Biosimilar Market Size and Growth Rate of Oncology Diseases from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Remicade Biosimilar Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Remicade Biosimilar Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Remicade Biosimilar Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Remicade Biosimilar Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Remicade Biosimilar Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Remicade Biosimilar

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Remicade Biosimilar by Different Types from 2016 to 2027

    • Table Consumption Share of Remicade Biosimilar by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of 100mg/10ml

    • Figure Market Size and Growth Rate of 500mg/50ml

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Remicade Biosimilar by Different End-Users from 2016 to 2027

    • Table Consumption Share of Remicade Biosimilar by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Blood Disorders

    • Figure Market Size and Growth Rate of Oncology Diseases

    • Table USA Remicade Biosimilar Production by Regions

    • Table USA Remicade Biosimilar Production Share by Regions

    • Figure USA Remicade Biosimilar Production Share by Regions in 2016

    • Figure USA Remicade Biosimilar Production Share by Regions in 2021

    • Figure USA Remicade Biosimilar Production Share by Regions in 2027

    • Table USA Remicade Biosimilar Consumption by Regions

    • Table USA Remicade Biosimilar Consumption Share by Regions

    • Figure USA Remicade Biosimilar Consumption Share by Regions in 2016

    • Figure USA Remicade Biosimilar Consumption Share by Regions in 2021

    • Figure USA Remicade Biosimilar Consumption Share by Regions in 2027

    • Table West USA Remicade Biosimilar Consumption by Types from 2016 to 2027

    • Table West USA Remicade Biosimilar Consumption Share by Types from 2016 to 2027

    • Figure West USA Remicade Biosimilar Consumption Share by Types in 2016

    • Figure West USA Remicade Biosimilar Consumption Share by Types in 2021

    • Figure West USA Remicade Biosimilar Consumption Share by Types in 2027

    • Table West USA Remicade Biosimilar Consumption by End-Users from 2016 to 2027

    • Table West USA Remicade Biosimilar Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Remicade Biosimilar Consumption Share by End-Users in 2016

    • Figure West USA Remicade Biosimilar Consumption Share by End-Users in 2021

    • Figure West USA Remicade Biosimilar Consumption Share by End-Users in 2027

    • Table South USA Remicade Biosimilar Consumption by Types from 2016 to 2027

    • Table South USA Remicade Biosimilar Consumption Share by Types from 2016 to 2027

    • Figure South USA Remicade Biosimilar Consumption Share by Types in 2016

    • Figure South USA Remicade Biosimilar Consumption Share by Types in 2021

    • Figure South USA Remicade Biosimilar Consumption Share by Types in 2027

    • Table South USA Remicade Biosimilar Consumption by End-Users from 2016 to 2027

    • Table South USA Remicade Biosimilar Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Remicade Biosimilar Consumption Share by End-Users in 2016

    • Figure South USA Remicade Biosimilar Consumption Share by End-Users in 2021

    • Figure South USA Remicade Biosimilar Consumption Share by End-Users in 2027

    • Table Middle West USA Remicade Biosimilar Consumption by Types from 2016 to 2027

    • Table Middle West USA Remicade Biosimilar Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Remicade Biosimilar Consumption Share by Types in 2016

    • Figure Middle West USA Remicade Biosimilar Consumption Share by Types in 2021

    • Figure Middle West USA Remicade Biosimilar Consumption Share by Types in 2027

    • Table Middle West USA Remicade Biosimilar Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Remicade Biosimilar Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Remicade Biosimilar Consumption Share by End-Users in 2016

    • Figure Middle West USA Remicade Biosimilar Consumption Share by End-Users in 2021

    • Figure Middle West USA Remicade Biosimilar Consumption Share by End-Users in 2027

    • Table Northeast USA Remicade Biosimilar Consumption by Types from 2016 to 2027

    • Table Northeast USA Remicade Biosimilar Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Remicade Biosimilar Consumption Share by Types in 2016

    • Figure Northeast USA Remicade Biosimilar Consumption Share by Types in 2021

    • Figure Northeast USA Remicade Biosimilar Consumption Share by Types in 2027

    • Table Northeast USA Remicade Biosimilar Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Remicade Biosimilar Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Remicade Biosimilar Consumption Share by End-Users in 2016

    • Figure Northeast USA Remicade Biosimilar Consumption Share by End-Users in 2021

    • Figure Northeast USA Remicade Biosimilar Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Celltrion

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celltrion

    • Figure Sales and Growth Rate Analysis of Celltrion

    • Figure Revenue and Market Share Analysis of Celltrion

    • Table Product and Service Introduction of Celltrion

    • Table Company Profile and Development Status of Novartis (Sandoz)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis (Sandoz)

    • Figure Sales and Growth Rate Analysis of Novartis (Sandoz)

    • Figure Revenue and Market Share Analysis of Novartis (Sandoz)

    • Table Product and Service Introduction of Novartis (Sandoz)

    • Table Company Profile and Development Status of Hospira

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hospira

    • Figure Sales and Growth Rate Analysis of Hospira

    • Figure Revenue and Market Share Analysis of Hospira

    • Table Product and Service Introduction of Hospira

    • Table Company Profile and Development Status of Genentech (Roche Group)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genentech (Roche Group)

    • Figure Sales and Growth Rate Analysis of Genentech (Roche Group)

    • Figure Revenue and Market Share Analysis of Genentech (Roche Group)

    • Table Product and Service Introduction of Genentech (Roche Group)

    • Table Company Profile and Development Status of Biocon

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biocon

    • Figure Sales and Growth Rate Analysis of Biocon

    • Figure Revenue and Market Share Analysis of Biocon

    • Table Product and Service Introduction of Biocon

    • Table Company Profile and Development Status of LG Life Sciences

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of LG Life Sciences

    • Figure Sales and Growth Rate Analysis of LG Life Sciences

    • Figure Revenue and Market Share Analysis of LG Life Sciences

    • Table Product and Service Introduction of LG Life Sciences

    • Table Company Profile and Development Status of Merck Serono (Merck Group)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck Serono (Merck Group)

    • Figure Sales and Growth Rate Analysis of Merck Serono (Merck Group)

    • Figure Revenue and Market Share Analysis of Merck Serono (Merck Group)

    • Table Product and Service Introduction of Merck Serono (Merck Group)

    • Table Company Profile and Development Status of Synthon Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Synthon Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Synthon Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Synthon Pharmaceuticals

    • Table Product and Service Introduction of Synthon Pharmaceuticals


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.